Actively Recruiting
Brain-lung Interaction During Acute Respiratory Failure
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-05-01
25
Participants Needed
2
Research Sites
39 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Acute hypoxemic de novo respiratory failure (AHRF) is a common cause of admission to the intensive care unit (ICU). Its main cause is community-acquired pneumonia. Prevention of intubation relies, among other things, on high-flow nasal canulae (HFNC). However, approximately 40% of patients are intubated despite HFNC. Our team has developed measurements derived from electroencephalograms (EEG) and near-infrared spectroscopy (NIRS) that enable the study of brain-ventilation interactions. To date, these tools have been studied exclusively in intubated patients. the investigators now wish to study them in non-intubated patients. The objective of this study is to investigate the relationship between the brain and lungs in adult patients admitted to the intensive care unit for acute hypoxemic respiratory failure and for whom the attending physician has decided to initiate HFNC. Before and one hour after the introduction of HFNC, electroencephalogram (EEG), near-infrared spectroscopy (NIRS), and electromyogram (EMG) of the Scalen muscles will be collected. From these recordings, the following variables will be collected: 1) The density of the gamma (30-100 Hz), beta (13-30 Hz), alpha (8-12 Hz), theta (4-8 Hz), and delta (0.5-4 Hz) frequency spectrum of the EEG in each of the following right and left cortical regions: medial region of the prefrontal cortex, anterior region of the cingulate gyrus, posterior region of the cingulate gyrus, insula, somatosensory cortex, angular gyrus, lateral prefrontal cortex, and supplementary motor area; 2) Connectivity between these regions for each frequency spectrum; 3) Pre-inspiratory potential; 4) Rieman classifier; 5) Coherence and Granger causality between each frequency spectrum and the scalene muscles EMG. These variables will be compared before and 1 hour after initiation of HFNC and between patients who will be intubated because of HFNC failure and those who will not.
CONDITIONS
Official Title
Brain-lung Interaction During Acute Respiratory Failure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 65 18 years
- Admitted to the intensive care within the last 48 hours
- De novo acute hypoxemic respiratory failure with an indication for high-flow nasal cannula (HFNC), defined by the combination of tachypnea > 25 breaths/min or labored breathing, PaO2/FiO2 64 200 mmHg, and unilateral or bilateral alveolar opacities on chest X-ray
- Decision by the attending physician to initiate HFNC treatment
- Patient or next of kin did not refuse participation after information (written informed consent waived)
You will not qualify if you...
- Exacerbation of an underlying chronic respiratory disease
- Acute cardiogenic pulmonary edema requiring non-invasive ventilation (NIV)
- Hypercapnia > 45 mmHg indicating NIV
- Glasgow Coma Scale score less than 13
- Imminent need for intubation
- Underlying central neurological disease likely to alter EEG signals
- Pregnancy or breastfeeding
- Lack of health insurance coverage
- Patient under legal protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Médecine Intensive - Réanimation, Hôpital Pitié Salpêtrière
Paris, France, 75013
Actively Recruiting
2
Service de Médecine Intensive et Réanimation, Hôpital Pitié Salpêtrière
Paris, France
Not Yet Recruiting
Research Team
A
Alexandre Demoule
CONTACT
M
Martin Dres
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here